A phase IV study of Apricity C.A.R.E. program for Cancer Adverse events Rapid Evaluation to improve treatment outcomes of ethnic/racial minority non-small cell lung cancer (NSCLC) patients receiving immunotherapy

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Nsclc
  • Age: Between 18 Year(s) - 100 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Confirmed non-small cell lung cancer (NSCLC) diagnosis
    2. Recommended to undergo a treatment using a type of medication called immune-checkpoint inhibitor. This medication may be given alone or in combination with chemotherapy.
    3. Self-identification as a member of an ethnic minority or underserved population

You may not be eligible for this study if the following are true:

    1. If the investigator believes that a person has any medical, psychological, or social condition that would make it impossible for them to participate in the study
    2. Currently participating in other clinical trials that involve some form of intervention at the time of screening
    3. Under the age of 18



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.